Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Donna Shu-Han Lin"'
Autor:
Donna Shu-Han Lin, Shian Chiuan Tzeng, Tai-Lung Cha, Chin-Mao Hung, Wen-Chin Lin, Chuen-Mi Yang, Hsuan-Ying Lu, Jia-Yu Chang, Shu-Wei Huang
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 56, Iss 5, Pp 951-960 (2023)
Background: Effective therapy for COVID-19 remains limited. Hydroxychloroquine (HCQ) has been considered, but safety and efficacy concerns remain. Chitosan exhibits antiviral and immunomodulatory effects, yet how the combination of HCQ and chitosan p
Externí odkaz:
https://doaj.org/article/9e594e49ab0d42febcbae9f5b98037aa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 23 (2023)
Background Although older patients with atrial fibrillation are at heightened risk of thromboembolic and bleeding events, their optimal treatment choice remains uncertain. Methods and Results This meta‐analysis was conducted according to the Prefer
Externí odkaz:
https://doaj.org/article/27135bbbfcd94a73a247c6af00e33403
Publikováno v:
Biology of Sex Differences, Vol 13, Iss 1, Pp 1-14 (2022)
Highlights Among patients with acute myocardial infarction (AMI), women were older, had more comorbid conditions, and were less likely to be discharged with optimal medical therapy than their male counterparts. In-hospital and long-term outcomes were
Externí odkaz:
https://doaj.org/article/209e25c8d3e64800a998f9564e49af2f
Autor:
Chih-Kuo Lee, Tzung-Dau Wang, Hsiao-Ting Juang, Shu-Chen Chang, Heng-Yu Pan, Donna Shu-Han Lin, Chee-Jen Chang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract The clinical efficacy of ticagrelor versus clopidogrel has not been replicated in East Asian populations. The pronounced bleeding risk with ticagrelor was of concern given the increased bleeding tendency in Asian populations. This study eval
Externí odkaz:
https://doaj.org/article/169d03786fa845b39a8e5826678efec5
Autor:
Donna Shu-Han Lin, Jen-Kuang Lee
Publikováno v:
JMIR mHealth and uHealth, Vol 10, Iss 6, p e39749 (2022)
In the “Patient Selection” section in Methods, “Patients with chronic foot ulcers were consecutively enrolled from the outpatient clinic or during admission from June 2019 to December 2019” should instead be “Patients with chronic foot ulce
Externí odkaz:
https://doaj.org/article/1878552b5dec46ea8c179bf55e0a003b
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 7 (2021)
Background This study compared the efficacy and safety between catheter‐directed thrombolysis (CDT) and systemic thrombolysis for patients with acute pulmonary embolism (PE) with midterm follow‐up. Methods and Results We conducted a prospective o
Externí odkaz:
https://doaj.org/article/05d62ce6c4964f91868abda48ab3d095
Publikováno v:
European Journal of Heart Failure. 25:98-107
Mineralocorticoid receptor antagonists (MRAs) have been shown to provide survival benefits in patients with heart failure; however, MRA use in patients with chronic kidney disease has been limited by safety concerns. The effects of MRAs on outcomes i
Publikováno v:
Diabetologia. 65:2032-2043
This study aimed to assess the real-world outcomes of people with diabetes mellitus treated with glucagon-like peptide-1 receptor agonists (GLP1RAs) compared with those treated with sodium-glucose cotransporter 2 inhibitors (SGLT2is) in terms of majo
Publikováno v:
International Journal of Obesity. 46:1425-1434
The "obesity paradox" - in which patients with obesity exhibit superior survival than normal-weight counterparts - has been reported for several diseases. However, obesity is a well-known risk factor for cardiovascular disease, and whether the obesit
Autor:
Donna Shu-Han Lin
Publikováno v:
Journal of the American College of Cardiology. 81:S346-S347